chrX-78657727-C-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_152694.3(RTL3):āc.694G>Cā(p.Glu232Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000992 in 1,209,214 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 8 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_152694.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000899 AC: 1AN: 111236Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 33406
GnomAD3 exomes AF: 0.0000165 AC: 3AN: 181747Hom.: 0 AF XY: 0.0000452 AC XY: 3AN XY: 66377
GnomAD4 exome AF: 0.0000100 AC: 11AN: 1097926Hom.: 0 Cov.: 31 AF XY: 0.0000220 AC XY: 8AN XY: 363304
GnomAD4 genome AF: 0.00000899 AC: 1AN: 111288Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 33468
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 04, 2023 | The c.694G>C (p.E232Q) alteration is located in exon 2 (coding exon 1) of the ZCCHC5 gene. This alteration results from a G to C substitution at nucleotide position 694, causing the glutamic acid (E) at amino acid position 232 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at